The Consortium of Rheumatology Researchers of North America, Inc. (CORRONA) was founded in 2000 by leading rheumatologists dedicated to advancing and improving the care of patients with rheumatic diseases.
CORRONA's mission is to advance rheumatology research and improve the quality of rheumatology patient care. CORRONA is an independent registry without any ownership links to the pharmaceutical industry.
The CORRONA research initiative consists of a database, data collection protocol and data analysis dedicated to the advancement of treatment of rheumatoid arthritis. It is our mission to provide excellence in the necessary interaction between the Clinicians and the scientific community to gather high quality data and data analysis for the advancement of treatment for the disease.
CORRONA and its adaptive database gathering technology are constantly changing with the marketplace and needs of the scientific community to collect, analyze and disseminate our expertise in the field of rheumatoid arthritis disease.
CORRONA is in constant motion with all quality control and quality assurance (QC/QA) checks to ensure accurate data reporting.
Through confirmation and validation, queries and constant communication with primary investigators and clinical coordinators at all sites, we strive to provide quality reporting. The CORRONA support staff takes careful measures to ensure the data being reported is accurate and true. The process is conducted with the assistance of staff, data programming, biostatisticians, and final reports are delivered after being reviewed by a professionally chosen group of physicians.
CORRONA takes responsibility for the publications and data reports knowing we are providing clear and accurate findings.